Results 131 to 140 of about 8,613,368 (310)

Is the antidepressant efficacy of ketamine and esketamine mediated via opioid mechanisms?

open access: yesEuropean Psychiatry
Background Ketamine and esketamine produce rapid and sustained antidepressant effects in persons with treatment-resistant depression (TRD). Although it is posited that these effects are largely attributed to N-methyl-D-aspartate receptor antagonism, the ...
Andy Lu   +11 more
doaj   +1 more source

Differential expression of cancer‐related genes supports prediction of poor response to first‐line treatments in T‐ALL pediatric patients with high minimal residual disease

open access: yesMolecular Oncology, EarlyView.
In the present work, we have identified a transcriptional signature based on the differential expression of six genes (BCL2&MAST4, HSH2D&LAT2, METRN&PITPNM2) that would facilitate the early detection of T‐cell acute lymphoblastic leukemia (T‐ALL) patients prone to a poor treatment response and could be implemented at diagnosis, along with other risk ...
Antonio Lahera   +11 more
wiley   +1 more source

A retrospective study of intramuscular clozapine prescription for treatment initiation and maintenance in treatment-resistant psychosis

open access: yes, 2020
Background Clozapine is uniquely effective in treatment-resistant psychosis but remains underutilised, partly owing to psychotic symptoms leading to non-adherence to oral medication. An intramuscular formulation is available in the UK but outcomes remain
Whiskey, E., Dzahini, O., Shergill, S.
core  

Real-world effectiveness and safety of xanomeline and trospium for treatment-resistant schizophrenia in a state hospital system

open access: yesFrontiers in Psychiatry
ObjectiveXanomeline and trospium (XT) is a novel medication for schizophrenia that was approved by the United States (U.S.) Food and Drug Administration (FDA) in September 2024.
Nina Vadiei   +4 more
doaj   +1 more source

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

open access: yesMolecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan   +16 more
wiley   +1 more source

Hijacking emergency granulopoiesis: Neutrophil ontogeny and reprogramming in cancer

open access: yesMolecular Oncology, EarlyView.
Neutrophils are highly plastic innate immune cells; their functions in cancer extend beyond the tumour microenvironment. This Review summarises current understanding of neutrophil maturation and heterogeneity and highlights tumour‐induced granulopoiesis as a systemic programme that expands immature, immunosuppressive neutrophils via tumour‐derived ...
Gabriela Marinescu, Yi Feng
wiley   +1 more source

Development of a multivariate prediction model for antidepressant resistant depression using reward-related predictors

open access: yesFrontiers in Psychiatry
IntroductionIndividuals with depression who do not respond to two or more courses of serotonergic antidepressants tend to have greater deficits in reward processing and greater internalizing symptoms, yet there is no validated self-report method to ...
Xiao Liu, Stephen J. Read
doaj   +1 more source

Transcriptional profiling of circulating extracellular vesicles from prebiopsy prostate cancer patients

open access: yesMolecular Oncology, EarlyView.
RNA profiling of circulating extracellular vesicles (EVs) from blood samples of men undergoing prostate biopsy identifies transcripts associated with clinically significant prostate cancer. Integrative analysis with public tumor datasets links EV‐derived gene signatures to tumor stage and progression‐free survival, highlighting CASP3, XRCC2, and RIT1 ...
Stefan Werner   +14 more
wiley   +1 more source

Evaluating Ketamine as a Therapeutic Option for Adults with Treatment Resistant Depression: A Systematic Review [poster] [PDF]

open access: yes
This systematic review examined the efficacy of ketamine therapy for treatment resistant depression in the adult population. A conceptual systematic review of the published peer-reviewed literature from the years 2014-2024 was conducted using Boolean ...
Kinney, Christina A.
core   +1 more source

Treatment-resistant DEK::AFF2 sinonasal squamous cell carcinoma: a case report and review of literature

open access: yesActa Oto-Laryngologica Case Reports
DEK::AFF2 fusion-associated sinonasal squamous cell carcinoma (SCC) is a rare and recently recognized malignancy, characterized by its deceptively bland histology and aggressive clinical behavior.
Wassim Najjar   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy